Archives of Pharmacal Research 2002-06-01

Crystal structure of byakangelicin (C17H18O7).

Yang Bae Kim, Yong Ho Oh, Il Yeung Park, Kuk Hyun Shin

Index: Arch. Pharm. Res. 25(3) , 275-9, (2002)

Full Text: HTML

Abstract

The crystal structure of byakangelicin, one of furanocoumarin aldose reductase inhibitors, was determined by X-ray diffraction method. The crystal is triclinic, with a = 8.114(1), b = 10.194(1), c = 11.428(1)A, a = 111.50(1), beta= 95.57(1), gamma = 112.52(1) degrees , Dx = 1.41, Dm = 1.39 g/cm3, space group P1 and Z = 2. The intensity data were collected by omega-2theta scan method with CuK(a) radiations. The structure was solved by direct method and refined by full matrix least-squares procedure to the final R-value of 0.056. There are two molecules with different conformations in an asymmetric unit. The molecules are kept by two intermolecular O-HO type hydrogen bonds and van der Waal's forces in the crystal. The absolute configuration of the molecules was estimated to S-form by the 'Eta refinement' procedure.


Related Compounds

Related Articles:

Simultaneous determination of byak-angelicin and oxypeucedanin hydrate in rat plasma by column-switching high-performance liquid chromatography with ultraviolet detection.

2001-04-05

[J. Chromatogr. B. Biomed. Sci. Appl. 753(2) , 309-14, (2001)]

[Studies on quality standards of radix Angelicae dahuricae].

2004-07-01

[Zhongguo Zhong Yao Za Zhi 29(7) , 654-7, (2004)]

Furocoumarins from Angelica dahurica with hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cells.

2002-05-01

[Planta Med. 68(5) , 463-4, (2002)]

High-performance liquid chromatographic method for the determination and pharmacokinetic study of oxypeucedanin hydrate and byak-angelicin after oral administration of Angelica dahurica extracts in mongrel dog plasma.

2007-05-09

[J. Pharm. Biomed. Anal. 44(1) , 166-72, (2007)]

Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes.

2011-01-01

[Br. J. Pharmacol. 162(2) , 441-51, (2011)]

More Articles...